Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: ALNYLAM PHARMACEUTICALS, INC., ALNYLAM PHARMACEUTICALS, INC. PAC, ALNYLAM PHARMACEUTICALS, INC.
Client-Reported Lobbying Expenses
$5.2M
164 filings
Firm Income Reported for This Client
$6.2M
Not substituted for client expenses
Contract Awards
$12.3M
4 awards
SEC Insider
$2.85B
3,263 transactions
Summary
Alnylam Pharmaceuticals, Inc. (ALNY) is an organization. Its political footprint includes $5.2 million in client-reported lobbying expenses, $6.2 million in lobbying-firm income reported for this client, $12.3 million in government contracts. Lobbying activity focuses on Medicare/Medicaid, Health Issues, Medical/Disease Research/Clinical Labs, Pharmacy. Their largest government contract source is Department of Health and Human Services at $8.8 million. Political activity spans from 2008 to 2026.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Lobbying Spend Trend
↓ 8% YoY
2025: $1.6M (complete years)
Insider Trading
54 insiders
Political Money Flow
Government agencies → Alnylam Pharmaceutical... (contracts) → political recipients & lobbying. Hover for details.